Newsletter

Pompe Disease
With one marketed therapy, and several in pipeline, Pompe disease market is anticipated to boost in the coming decade

More Whitepapers / Newsletters

Duchenne Muscular Dystrophy Newsletter
Duchenne Muscular Dystrophy

A genetic disorder, Duchenne Muscular Dystrophy (DMD), is a progressive form of muscular dystrophy with a higher preponderance in males..

Impact of BREXIT on Pharma Space Newsletter
Impact of BREXIT on Pharma Space

BREXIT, the 'EXIT' of 'BRITAIN' from 'EUROPEAN UNION', shook the whole world when the United Kingdom voted in the favor of leaving the EU.

An Abundance Of Rare Newsletter
An Abundance Of Rare

Though appear rare, rare diseases are far from being rare. With over 7,000 rare disease affecting millions worldwide.

Evolution of Precision Medicine in Oncology Whitepaper
Evolution of Precision Medicine in Oncology

Past decades have witnessed a shift in the focus of researchers and pharma companies towards tailoring the treatment approach and..

Fragile X Syndrome Newsletter
Fragile X Syndrome

Fragile X Syndrome is a syndrome, which results in intellectual disabilities as well as affects the physical characteristics of the people..